Teresa Lanza DI Scalea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Teresa Lanza DI Scalea has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Katherine L. Wisner
Developing Brain Institute, Children’s National Hospital, Washington, DC 20010, USA
2 shared publications
Latest Publications
- 30 October 2009
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 10 (16) , 2593-2607
Pharmacotherapy of postpartum depression
Background: The prevalence and recurrence rates of postpartum depression (PPD) are 13 and 25%, respectively. Despite its detrimental impact on the health of the mother–infant dyad, there is a pauci...
- 30 October 2009
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 10 (16) , 2593-2607
Pharmacotherapy of postpartum depression
Background: The prevalence and recurrence rates of postpartum depression (PPD) are 13 and 25%, respectively. Despite its detrimental impact on the health of the mother–infant dyad, there is a pauci...
- 1 September 2009
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 52 (3) , 483-497
Antidepressant Medication Use During Breastfeeding
We performed an electronic search by using MEDLINE, PreMEDLINE, Current Contents, Biological Abstracts, and PsycINFO from June 2002 to December 2008 using the following terms: “antidepressant drugs”, “antidepressive agents”, “human milk”, “lactation”, and “breastfeeding” and the generic name of each antidepressant. Articles in the English language with reports of antidepressants in maternal serum or breast milk, infant serum, and short-term and long-term clinical outcomes in the infants were obtained. The search yielded a total of 31 empirical papers. Breastfeeding and antidepressant treatments are not mutually exclusive. Sertraline, paroxetine, nortriptyline, and imipramine are the most evidence-based medications for use during breastfeeding.
- 1 September 2009
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 52 (3) , 483-497
Antidepressant Medication Use During Breastfeeding
We performed an electronic search by using MEDLINE, PreMEDLINE, Current Contents, Biological Abstracts, and PsycINFO from June 2002 to December 2008 using the following terms: “antidepressant drugs”, “antidepressive agents”, “human milk”, “lactation”, and “breastfeeding” and the generic name of each antidepressant. Articles in the English language with reports of antidepressants in maternal serum or breast milk, infant serum, and short-term and long-term clinical outcomes in the infants were obtained. The search yielded a total of 31 empirical papers. Breastfeeding and antidepressant treatments are not mutually exclusive. Sertraline, paroxetine, nortriptyline, and imipramine are the most evidence-based medications for use during breastfeeding.